Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6150)
All Articles published online
|
Publishing Process of This Article
|
Feb 10, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Obstetrics and Gynecology
ISSN
2218-6220
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Deutsch D, Deen S, Entschladen F, Coveney C, Rees R, Zänker KS, Powe DG. Alpha1B adrenoceptor expression is a marker of reduced survival and increased tumor recurrence in patients with endometrioid ovarian cancer. World J Obstet Gynecol 2016; 5(1): 118-126 [DOI: 10.5317/wjog.v5.i1.118] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6220/full/v5/i1/118.htm |
| Number | Citing Articles |
| 1 |
Francesca Broso, Pamela Gatto, Viktoryia Sidarovich, Chiara Ambrosini, Veronica De Sanctis, Roberto Bertorelli, Elena Zaccheroni, Benedetta Ricci, Eliana Destefanis, Sara Longhi, Enrico Sebastiani, Toma Tebaldi, Valentina Adami, Alessandro Quattrone. Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation. Cancer Research 2023; 83(16): 2733 doi: 10.1158/0008-5472.CAN-22-1913
|
| 2 |
G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules. International Journal of Molecular Sciences 2019; 20(22): 5568 doi: 10.3390/ijms20225568
|